|
|
||||||||
1 Laboratoire d'Optique
Appliquée, Isotonic and isometric properties of nine human bronchial smooth
muscles were studied under various loading and tone conditions. Freshly
dissected bronchial strips were electrically stimulated successively at
baseline, after precontraction with
10
airways; methacholine; albuterol
ALTHOUGH THE PHYSIOLOGICAL role of airway smooth muscle
is not completely understood, it is well established that the
maintenance of airway tone and volume is one of its most important
functions. As airway smooth muscle is constantly subjected to changes
in length and load during breathing (22), it regulates airflow to the
lungs via shortening and elongation (17). It is thus important to
measure not only isometric parameters, but also length and force
changes during isotonic contraction and relaxation processes, to
precisely study the mechanics of airway smooth muscle. Recent studies
of isotonic mechanical properties of isolated human bronchial smooth
muscle (HBSM) have been published (4, 14, 18, 24); all these studies
deal with electrically stimulated muscles at baseline. Other studies
have described the isometric properties of HBSM exposed to electrical
field stimulation (EFS). In some of them, a transient decrease in
tension below baseline was noticed after the initial EFS-elicited
contraction, whether HBSM was studied under spontaneous tone (3, 8, 19,
27, 28, 35) or precontracted with histamine (8, 10, 19, 26, 28, 35), carbachol (9), or methacholine (MCh) (2). However, the mechanical characteristics and physiological significance of this phase of decline
in tension below baseline remain poorly documented.
The purpose of the present study was to test the influence of load and
tone changes on the isotonic and isometric mechanical properties of
isolated HBSM. We hypothesized that an increase in basal tone, i.e., a
precontraction, should act by increasing the number of active
actomyosin cross bridges under resting conditions before the
EFS-elicited contraction. If total resting tension (RT) is
experimentally held constant, pharmacologically induced tone should
increase the active part of RT, called the active RT or active
"intrinsic tone" (11). Therefore, fewer cycling cross bridges
should be available during the electrically induced contraction: muscle
shortening and tension development should be limited. Conversely,
removal of this tone should restore contractile parameters to baseline
values by restoring more available cross bridges for the EFS-induced
contraction. In this study we compared with baseline and under various
loading conditions the effects of 1)
the increase in tone with MCh and 2)
the removal of this tone by addition of albuterol (Alb) on the three
known EFS-elicited processes: contraction, relaxation, and decrease in
tension below baseline.
Bronchial Smooth Muscle Preparation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
7 M methacholine (MCh),
and after relaxation with
10
5 M albuterol (Alb).
Resting tension, i.e., preload determining optimal initial length
(Lo) at
baseline, was held constant. Compared with baseline, MCh decreased
muscle length to 93 ± 1%
Lo
(P < 0.001) before any electrical
stimulation, whereas Alb increased it to 111 ± 3%
Lo
(P < 0.01). MCh significantly
decreased maximum unloaded shortening velocity (0.045 ± 0.007 vs.
0.059 ± 0.007 Lo/s), maximal
extent of muscle shortening (8.4 ± 1.2 vs. 13.9 ± 2.4%
Lo), and peak
isometric tension (6.1 ± 0.8 vs. 7.2 ± 1.0 mN/mm2). Alb restored all these
contractile indexes to baseline values. These findings suggest that MCh
reversibly increased the number of active actomyosin cross bridges
under resting conditions, limiting further muscle shortening and active
tension development. After the electrically induced contraction,
muscles showed a transient phase of decrease in tension below preload.
This decrease in tension was unaffected by afterload levels but was
significantly increased by MCh and reduced by Alb. These findings
suggest that the cross bridges activated before, but not during, the
electrically elicited contraction may modulate the phase of decrease in
tension below preload, reflecting the active part of resting tension.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
Electromagnetic Lever System
The electromagnetic device has been previously described for skeletal muscle experiments (6, 20). Briefly, it consists of an aluminum lever that is cemented to a coil suspended in the strong field of a permanent magnet. A force couple develops when an electric current passes through the coil. The vector moment of the force couple (M) acting on the coil at the fulcrum is given by Lorentz's law: M = B · n · l · d · I, where B is the magnetic induction, n is the number of turns, l is the length of the coil, d is the width of the coil, and I is the current intensity. At the tip of the aluminum lever of length L, the tangential force (F) is M/L. This force is always perpendicular to the lever. The vertical component of F (same direction as that of muscle force and shortening) does not change considerably, because it depends on the cosine of the angle
due to the small displacement of the
lever from its horizontal position during muscle shortening. Force
measurement amplitude ranges from 0 to 140 mN. The error in measured
force is <0.1%. The equivalent moving mass of the whole
system is 155 mg. Its compliance is equal to 0.2 µm/mN. The
displacement of the lever is measured by means of a photoelectric
transducer that consists of an incandescent lamp, a miniature
photodiode, and a preamplifier acting as a current-to-voltage converter. The light emitted by the lamp is modulated by the
displacement of the lever, and current alterations in the photodiode
are converted into voltage alterations. The linearity of the system
ranges up to 5 mm of muscle shortening. The error in measured
displacement is <0.5% of the full-scale deflection. A length-stop
system allows muscle length changes between each protocol, so that
preload remains constant throughout the whole experiment, except at the
beginning of the procedure, when optimal initial muscle length
(Lo) is determined.
All analyses were made from digital recordings obtained by means of a personal computer. Two signals were recorded: force and length. The recording speed was one analog-to-digital conversion of each signal every 1 ms. Total recording time ranged from 45 to 300 s. A homemade program was used to calculate mechanical parameters.
Mechanical Parameters
In isolated muscle terminology, preload determines resting initial muscle length and represents the RT that stretches the muscle before stimulation. Total RT is divided into active and passive components (16). During an EFS-elicited contraction, total tension is the sum of RT (preload) and active isometric tension (afterload).At the end of the equilibration period, the resting length of the
preparations was progressively increased: step by step, preloads
ranging from 10 to 25 mN were applied 10 min before stimulation of
muscle strips under fully isometric load.
Lo was defined as the length at which the peak value of active isometric tension was
measured. This procedure was used to assess the shallow maximum of the
length-tension curve (23), and thus the optimal preload that was held
constant until the end of the study. RT
(mN/mm2) was defined as
normalized preload. Mechanical parameters characterizing EFS-induced
contraction-relaxation required at least three loading conditions to be
measured (Fig. 1).
Contraction 1 was loaded with preload
only and abruptly clamped to zero load 4 ms after the onset of the
electrical stimulus, according to the "zero-load clamp" technique
(5). Contraction 2 was loaded with
preload only. Contraction 3 was
carried out against a heavy load that the muscle could not overcome, so
its contraction was fully isometric.
|
During the EFS-elicited contraction phase, we recorded (Fig. 1) maximum
unloaded shortening velocity of contraction
1 (Vmax, Lo/s), maximum
extent of muscle shortening of contraction
2 (
L, %Lo), peak
isometric force of contraction 3 (Fo, mN)
converted to peak isometric tension
(Po,
mN/mm2) when normalized per
cross-sectional area, and positive peak of isometric tension derivative
of contraction 3 (+dPo/dt,
mN · mm
2 · s
1).
During the EFS-elicited relaxation phase, we recorded the maximum
lengthening velocity of contraction 2 (Vr,
Lo/s) and the negative peak of isometric tension derivative of
contraction 3 (
dPo/dt,
mN · mm
2 · s
1;
Fig. 1).
After the contraction-relaxation process, tension fell below preload
and spontaneously reverted to preload level in 3-4 min. During
this phase of decrease in tension below preload, the lowest measurable
tension was termed
P2
(mN/mm2). The maximum extent of
decline in tension below preload
(
P1, mN/mm2) was calculated as the
difference between RT and
P2
(Fig. 1):
P1 = RT
P2.
Experimental Protocols
Three protocols were successively carried out in an attempt to analyze the effects of load and tone changes on isolated HBSM mechanics.Protocol 1. At Lo, isotonic and isometric mechanical parameters were recorded at baseline throughout the load continuum, i.e., during 6-10 EFS-elicited contractions against increasing loads, from zero load up to the fully isometric contraction.
Protocol 2.
The muscarinic agonist MCh (MCh chloride,
10
7 M; Pharmacie Centrale
des Hôpitaux de Paris) was added to the bath to precontract bronchial smooth muscle (MCh-induced tone). At 15 min after MCh addition, mechanical parameters were recorded at zero load, at preload
only, and under isometric conditions.
Protocol 3.
The
2-adrenoceptor agonist Alb
(10
5 M; GlaxoWellcome) was
added to the bath containing MCh to relax HBSM, i.e., to antagonize prior MCh-induced tone. Again, EFS was delivered 15 min after Alb
addition, and mechanical parameters were recorded at zero load, at
preload only, and under isometric conditions.
Statistical Analysis
Values are means ± SE. Statistical analyses were carried out by using ANOVA and Student's t-test for paired observations; P values were indicated after Bonferroni's correction was taken into account. P < 0.05 was considered statistically significant.| |
RESULTS |
|---|
|
|
|---|
Mechanical Parameters at Baseline
At baseline, electrically stimulated HBSM produced a contraction phase followed by a relaxation phase and a phase of decrease in tension below preload (Fig. 1). During the contraction phase, peak isometric force was 37.8 ± 4.6 mN, equivalent to Po reaching 7.2 ± 1.0 mN/mm2 when normalized per cross-sectional area. Mean cross-sectional area was 5.59 ± 0.73 mm2. Mean RT at Lo was 2.5 ± 0.4 mN/mm2. At Lo,
P1 represented 24 ± 7% of
total RT. The
P1 index was not
altered by the afterload applied during the contraction phase (Fig.
2): during the phase of decrease in tension
below preload, all tension curves were superimposed regardless of the
afterload level.
|
Mechanical Parameters in MCh-Precontracted HBSM
Figure 3 illustrates the effects of 10
7 M MCh on initial muscle
length before any EFS. Under preload determining
Lo at baseline, MCh precontracted HBSM, i.e., reduced initial muscle length to 93 ± 1% Lo
(P < 0.001). These length changes
occurred during the first 30 s after MCh addition and reached a steady
maximum after 8-10 min. Muscle length remained stable for
1 h.
|
Effects of MCh on the EFS-elicited contraction phase, the relaxation
phase, and the phase of decrease in tension below preload are
illustrated by a typical experimental recording (Fig.
4). Compared with baseline, MCh decreased
each contractile parameter. Isometric indexes
Po (Fig.
5A) and
+dPo/dt
(Fig. 5B) decreased by 16 ± 3 and 23 ± 4% of their values at baseline, respectively, whereas
isotonic indexes
Vmax (Fig.
5C) and
L (Fig.
5D) both decreased by 30 ± 5%.
During the EFS-elicited relaxation, MCh lowered
Vr by 19 ± 5% (Fig.
6A),
whereas
dPo/dt
was not significantly modified (Fig.
6B). Finally, MCh markedly increased
the extent of the phase of decrease in tension below preload in each
tested muscle strip (Fig.
7A):
P1 was 85 ± 31% higher
after MCh exposure than at baseline (Fig.
7B).
|
|
|
|
Mechanical Parameters in Alb-Relaxed HBSM
Figure 3 illustrates the effects of 10
5 M Alb on initial muscle
length before any EFS. Under preload determining
Lo at baseline, Alb relaxed precontracted HBSM; i.e., initial muscle length increased beyond Lo: mean
muscle length was 111 ± 3%
Lo after Alb
exposure (P < 0.01; Fig.
3B).
Effects of Alb on the EFS-elicited contraction phase, the relaxation
phase, and the phase of decrease in tension below preload are depicted
in Figs. 5, 6, and 7, respectively. Alb restored all contractile
indexes to baseline values (Fig. 5). During the relaxation phase, Alb
did not change
dPo/dt
(Fig. 6B), whereas Vr increased by
28 ± 9% compared with baseline values (Fig.
6A). The phase of decrease in
tension below preload totally disappeared in five of nine muscles
exposed to Alb, and
P1 was
markedly decreased in the four other muscles (Fig. 7).
| |
DISCUSSION |
|---|
|
|
|---|
The present study describes the isotonic and isometric mechanical properties of electrically stimulated HBSM submitted to various tone and loading conditions. At preload determining Lo at baseline, our results showed that 1) contractile indexes were lowered when tone was increased with MCh and were restored to baseline values when this tone was removed with Alb, 2) isotonic relaxation was slower when tone was increased and faster when tone was reduced, whereas isometric relaxation was unaltered by tone changes, and 3) after the contraction-relaxation process, muscles exhibited a transient phase of decrease in tension below preload, which was unaltered by the afterload level applied during the contraction, greatly reinforced when tone was increased, and markedly reduced when tone was decreased.
There are relatively few quantitative data concerning the isotonic and
isometric mechanical properties of isolated HBSM at baseline. In our
study, values of the maximum shortening of the contraction with preload
only (
L) and
Vmax were
comparable to those previously reported in HBSM (4, 14, 18, 24). The same is true for Po (18), but data
are more difficult to compare because of the different methods used to
normalize force parameters, even if the most suitable way to normalize
force in airway smooth muscle is use of the ratio of muscle
cross-sectional area to total tissue cross-sectional area (32). The
values of Po,
L, and Vmax reported in
HBSM are lower than those observed in canine (34), porcine (13), and
rabbit (29) tracheal smooth muscle. Morphometric evaluations of muscle
cross-sectional area have demonstrated the smaller amount of smooth
muscle in HBSM strips (4, 14) than in porcine (13), guinea pig (25),
and rat (25) tracheal smooth muscle. This may account for the lower
isometric tension observed in HBSM. Moreover, a high percentage of
connective tissue in HBSM may act as an important parallel elastic
component. This may increase the load facing the muscle, limiting
muscle-shortening ability (14). Jiang et al. (18) also suggested that
the lower values of
L and
Vmax in HBSM
(which are independent of the method used to normalize force
parameters) may reflect different properties of the actomyosin ATPase.
Further studies are required to confirm these hypotheses.
At baseline, electrically stimulated muscles exhibited a transient phase of decrease in tension below preload after the contraction-relaxation process. Such a phase of decrease in tension below baseline has been previously reported in some but not all species. Electrically stimulated tracheal smooth muscles of dog (31, 34), pig (13), rabbit, and rat (personal observations) usually display no decrease in tension below baseline. Conversely, the phase of decrease in tension below preload has been extensively described in the airway smooth muscle of guinea pig at baseline (7). Recent studies have disclosed that nitric oxide is one of the intracellular agents mediating the phase of decrease in tension below baseline in HBSM (2, 3), whereas vasoactive intestinal peptide seems predominant in that of guinea pig (36). Data concerning the role of the endogenous prostaglandin E2 are still controversial in HBSM: some authors have reported a reduction in spontaneous tone with the cyclooxygenase inhibitor indomethacin (15), whereas others have noticed that baseline spontaneous tone is usually not affected by indomethacin addition (10, 11, 19). If prostaglandin E2 has a role, it may be a minor one in the phase of tension below preload observed in electrically stimulated HBSM.
To mechanically describe the phase of decrease in tension below
preload, we proposed a calculated index,
P1, i.e., RT
P2. At
Lo, mean
P1 represented 24 ± 7% of
RT. The decrease of tension below baseline spontaneously reverted to
preload level in 3-4 min. This is consistent with an active
phenomenon underlying the phase of decrease in tension below preload.
Thus
P1 may partly reflect the
active part of RT, in other words, part of active intrinsic
tone (11). However, our experimental method does not make
it possible to consider
P1 as
an index of the entire intrinsic tone, inasmuch as one cannot exclude
that a small part of
P2 is
active. In our model we can only assert that the active part of RT was
at least equal to 24 ± 7% of total RT at
Lo. Furthermore,
P1 was unaltered by the level
of afterload applied during the contraction (Fig. 2). This suggests
that distinct intracellular mechanisms modulate the EFS-elicited
contraction phase and the phase of decrease in tension below preload.
The phase of decrease in tension below preload appeared to be
insensitive to changes in general loading conditions affecting the
muscle during EFS-elicited contraction.
To raise tone, MCh was chosen, because it is known to directly act on
smooth muscle, mainly via M3
receptors (30), and to produce a stable contraction (2). Moreover, the
main other pharmacological agent known to raise tone, i.e., histamine,
has been shown to be particularly susceptible to oxidation when EFS is
performed in KH oxygenated solution (12). In our experimental procedure, RT was held constant, so that MCh precontraction expressed itself by reducing HBSM initial length (Fig. 3). Moreover, MCh enhanced
the amount of the active part of RT. Figure 7 shows that
P1 was indeed enhanced by MCh:
the higher the active part of RT, the higher the decrease of tension
below preload. This suggests that raising tone with MCh activates
additional actomyosin cross bridges before the EFS-elicited contraction
phase. The newly activated cross bridges might be slowly cycling rather
than normally cycling, as the former is considered to be activated
within 2 s of shortening (or force production) and a period of 15 min
was allowed to elapse before the mechanical parameters were measured in
MCh-precontracted muscles.
It would have been interesting to accurately specify the types of activated actomyosin cross bridges by performing quick-release and quick-stretch studies. In fact, such techniques enable measurement of instantaneous stiffness, which is known to reflect the elastic properties of the muscle series elastic component and to be directly proportional to the number of attached (or active) cross bridges (33). Such studies, although elegant in indirectly estimating the number of cycling cross bridges, do not make it possible to differentiate normally cycling from slowly cycling cross bridges. In the present study it was decided to work at constant preload throughout the experiment, thus allowing length changes after addition of MCh or Alb. We believe that additional changes in muscle length (e.g., quick release and quick stretch) would have hampered the interpretation of the mechanical results. This question should certainly be investigated further.
Compared with baseline and for a given RT set by the preload
determining Lo at
baseline, MCh lowered isotonic shortening and isometric tension (Fig.
5). As mentioned above, the number of the cross bridges activated
before the EFS-elicited contraction phase was thought to have been
increased by MCh. This would tend to reduce the number of the cross
bridges available during the subsequent contraction-relaxation process:
such a mechanism could explain lowered muscle shortening and tension
development observed in MCh-precontracted HBSM during the EFS-elicited
process. An alternative mechanism could be that the cross bridges
activated by MCh (presumably slowly cycling cross bridges) act as an
internal resistance to shortening, thus reducing velocity (33). Even after MCh exposure,
P1 was not
affected by the various afterload levels applied during the contractile
phase, confirming that the cross bridges formed during the EFS-elicited
contraction (normally and slowly cycling cross bridges) did not
modulate the phase of decrease in tension below preload.
For further insight into the role of tone changes on the mechanical
behavior of electrically stimulated isolated HBSM, we abolished the
previous pharmacologically induced tone and measured the same indexes
in the same muscles. We chose a massive dose (10
5 M) of a widely used
bronchorelaxant drug, Alb. We checked its effectiveness by measuring
initial muscle length without changes in total RT. It seemed
conceivable that any possible muscle lengthening occurring before EFS
could result from a release of the additional cross bridges activated
during MCh exposure. As expected, the major bronchorelaxant potency of
Alb induced a lengthening of muscle strips beyond
Lo (Fig. 3). With
similar Alb concentrations, previous isometric studies have shown that
the maximal EFS-elicited tension developed by isolated HBSM is markedly
reduced (27). In contrast, the present results showed that peak
isometric tension and
+dPo/dt
did not significantly differ from baseline if one allowed changes in
initial muscle length (Fig. 5). It is important to consider that, in
vivo, airway smooth muscle contracts and relaxes auxotonically: as the
muscle shortens, load increases (21). Auxotonic loading increases the
contractility of airway smooth muscle (21), which can offset, to some
extent, the effect of increasing load. It seems unlikely that Alb could
lead to a decrease in tension without changes in initial muscle length
in vivo. Our experimental data demonstrated that Alb actually relaxed precontracted HBSM without any decline in its ability to develop isometric tension.
As expected, Alb restored
Vmax and
L to baseline values (Fig. 5). This
confirmed the role of tone changes in the variations of contractile
parameters: contractile indexes were decreased by raising active
intrinsic tone and were immediately and completely restored by removing
MCh-induced tone. Interestingly, isotonic relaxation was faster when
tone was decreased (Fig. 6A),
whereas isometric relaxation was unaffected by tone changes (Fig.
6B). Further studies are needed to
elucidate the underlying mechanisms.
The transient phase of decrease in tension below preload was totally
abolished by Alb exposure in five of nine of the tested muscles and was
markedly reduced for the remaining four muscles (Fig. 7). This
observation indirectly reinforced the idea that
P1 represented a part of active
RT: as Alb induced a muscle lengthening before EFS, the active
component of RT was lowered; at the same time,
P1 was markedly lowered. On the
other hand, the effects of Alb could not be attributed to changes in
initial muscle length: at baseline,
P1 increased as initial muscle
length increased (personal observation), so that
P1 should have been enhanced by
Alb if it was markedly influenced by changes in muscle length.
Limitations of our experimental data need to be discussed. Each HBSM was obtained from a patient suffering from carcinoma. Only macroscopically tumor-free specimens were dissected, but we cannot assert that all HBSM were histologically tumor free. However, it is difficult to study the HBSM of tumor-free patients for ethical reasons. Moreover, a recent study has shown similar responses between the EFS-induced isometric contractions of HBSM resected for carcinoma and nondiseased (donor lung) specimens (1). To eliminate a time-induced artifact in our observed experimental data, it would have been useful to investigate a time-matched control group. However, none of the contractile mechanical parameters significantly differed from baseline at the end of protocol 3, i.e., Alb exposure (Fig. 5). Thus the contractile apparatus proved to be functional over a long period of time. Moreover, this type of preparation is often used in mechanical studies and is reputed to be stable for 4-6 h (33). Therefore, it seems unlikely that MCh-elicited changes could be attributed to time-induced damage.
In summary, at preload determining Lo at baseline, our study showed that 1) isotonic and isometric contractile parameters were reversibly lowered by increases in the active component of resting tone, 2) tone changes influenced the isotonic, but not the isometric, relaxation process, and 3) electrically stimulated HBSM exhibited a transient phase of decrease in tension below preload, which proved to be insensitive to afterload but greatly modulated by tone. This specific phase of tension below preload could represent at least part of the active RT. Our results suggest that in isolated HBSM the number of the cycling actomyosin cross bridges activated before, but not during, an electrically elicited contraction partly modulated the mechanical characteristics of the EFS-elicited contraction and the extent of decrease in tension below baseline.
| |
FOOTNOTES |
|---|
Address for reprint requests: Y. Lecarpentier, INSERM Unité 451, LOA, ENSTA, Batterie de l'Yvette, 91125 Palaiseau Cédex, France.
Received 17 September 1997; accepted in final form 28 September 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Armour, C. L.,
K. O. McKay,
P. R. A. Johnson,
A. R. Glanville,
and
J. L. Black.
Does the disease state influence the responsiveness of human airways studied in vitro?
J. Appl. Physiol.
80:
2211-2216,
1996
2.
Bai, T. R.,
and
A. M. Bramley.
Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi.
Am. J. Physiol.
264 (Lung Cell. Mol. Physiol. 8):
L425-L430,
1993
3.
Belvisi, M. G.,
C. D. Stretton,
M. Miura,
G. M. Verleden,
S. Tadjkarimi,
M. H. Yacoub,
and
P. J. Barnes.
Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter.
J. Appl. Physiol.
73:
2505-2510,
1992
4.
Bramley, A. M.,
R. J. Thomson,
C. R. Roberts,
and
R. R. Schellenberg.
Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance.
Eur. Respir. J.
7:
337-341,
1994[Abstract].
5.
Brutsaert, D. L.,
V. A. Claes,
and
E. H. Sonnenblick.
Velocity of shortening of unloaded heart muscle and the length-tension relation.
Circ. Res.
29:
36-75,
1971.
6.
Coirault, C.,
D. Chemla,
N. Péry,
I. Suard,
and
Y. Lecarpentier.
Mechanical determinants of isotonic relaxation in isolated diaphragm muscle.
J. Appl. Physiol.
75:
2265-2272,
1993
7.
Coleman, R. A.,
and
G. P. Levy.
A non-adrenergic inhibitory nervous pathway in guinea-pig trachea.
Br. J. Pharmacol.
52:
167-174,
1974[Medline].
8.
Davis, C.,
M. S. Kannan,
T. R. Jones,
and
E. E. Daniel.
Control of human airway smooth muscle: in vitro studies.
J. Appl. Physiol.
53:
1080-1087,
1982
9.
Doidge, J. M.,
and
D. G. Satchell.
Adrenergic and non-adrenergic inhibitory nerves in mammalian airways.
J. Auton. Nerv. Syst.
5:
83-99,
1982[Medline].
10.
Ellis, J. L.,
and
B. J. Undem.
Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airways.
Am. Rev. Respir. Dis.
146:
1543-1547,
1992[Medline].
11.
Ellis, J. L.,
and
B. J. Undem.
Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi.
Am. J. Respir. Crit. Care Med.
149:
118-122,
1994[Abstract].
12.
Hulsmann, A. R.,
H. R. Raatgeep,
I. M. Garrelds,
A. W. M. Toorenenbergen,
and
J. C. de Jongste.
Electrical field stimulation causes oxidation of exogenous histamine in Krebs-Henseleit buffer: a potential source of error in studies of isolated airways.
J. Pharmacol. Toxicol. Methods
30:
149-152,
1993[Medline].
13.
Ishida, K.,
P. D. Paré,
T. Blogg,
and
R. R. Schellenberg.
Effects of elastic loading on porcine trachealis muscle mechanics.
J. Appl. Physiol.
69:
1033-1039,
1990
14.
Ishida, K.,
P. D. Paré,
J. Hards,
and
R. R. Schellenberg.
Mechanical properties of human bronchial smooth muscle in vitro.
J. Appl. Physiol.
73:
1481-1485,
1992
15.
Ito, Y.,
H. Suzuki,
H. Aizawa,
H. Hakoda,
and
T. Hirose.
The spontaneous electrical and mechanical activity of human bronchial smooth muscle: its modulation by drugs.
Br. J. Pharmacol.
98:
1249-1260,
1989[Medline].
16.
Jain, M.,
H. B. Dai,
J. P. Carrozza,
F. W. Sellke,
and
K. G. Morgan.
Intrinsic tone as potential vascular reserve in conductance and resistance vessels.
Circulation
94:
1083-1088,
1996
17.
Jiang, H.,
and
N. L. Stephens.
Isotonic relaxation of sensitized bronchial smooth muscle.
Am. J. Physiol.
262 (Lung Cell. Mol. Physiol. 6):
L344-L350,
1992
18.
Jiang, H.,
X. Su,
H. Unruh,
and
N. L. Stephens.
Isotonic and isometric properties of human bronchial smooth muscle (Abstract).
Am. J. Respir. Crit. Care Med.
149:
A905,
1994.
19.
de Jongste, J. C.,
H. Mons,
I. L. Bonta,
and
K. F. Kerrebijn.
Nonneuronal components in the response of fresh human airways to electric field stimulation.
J. Appl. Physiol.
63:
1558-1566,
1987
20.
Lecarpentier, Y.,
C. Coirault,
G. Lerebours,
P. Desche,
E. Scalbert,
F. Lambert,
and
D. Chemla.
Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated Bio 53-58 strain.
Am. J. Respir. Crit. Care Med.
155:
630-636,
1997[Abstract].
21.
Li, W.,
and
N. L. Stephens.
Auxotonic loading and airway smooth muscle shortening.
Can. J. Physiol. Pharmacol.
72:
1458-1463,
1994[Medline].
22.
Mehta, D.,
M. F. Wu,
and
S. J. Gunst.
Role of contractile protein activation in the length-dependent modulation of tracheal smooth muscle force.
Am. J. Physiol.
270 (Cell Physiol. 39):
C243-C252,
1996
23.
Mitchell, H. W.,
and
M. P. Sparrow.
Methods of studying airway smooth muscle.
In: Asthma and Rhinitis, edited by W. W. Busse,
and S. T. Holgate. Boston: Blackwell Scientific, 1995, p. 1116-1134.
24.
Mitchell, R. W.,
E. Rühlmann,
H. Magnussen,
A. R. Leff,
and
K. F. Rabe.
Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity.
Am. J. Physiol.
267 (Lung Cell. Mol. Physiol. 11):
L218-L222,
1994
25.
Opazo-Saez, A. M.,
M. Ludwig,
and
P. D. Paré.
Differences in airway responsiveness between rats and guinea pigs are not related to in-vitro tracheal smooth muscle (TSM) contractility (Abstract).
Am. J. Respir. Crit. Care Med.
153:
A874,
1996.
26.
Palmer, J. B. D.,
F. M. C. Cuss,
and
P. J. Barnes.
VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways.
J. Appl. Physiol.
61:
1322-1328,
1986
27.
Rhoden, K. J.,
L. A. Meldrum,
and
P. J. Barnes.
Inhibition of cholinergic neurotransmission in human airways by
2-adrenoceptors.
J. Appl. Physiol.
65:
700-705,
1988
28.
Richardson, J.,
and
J. Béland.
Nonadrenergic inhibitory nervous system in human airways.
J. Appl. Physiol.
41:
764-771,
1976
29.
Roepke, D. A.,
S. L. Griffith,
R. A. Meiss,
R. A. Rhoades,
and
C. S. Packer.
Contractility and myosin heavy chain isoform patterns in developing tracheal muscle.
Respir. Physiol.
98:
101-110,
1994[Medline].
30.
Roffel, A. F.,
C. R. S. Elzinga,
and
J. Zaagsma.
Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle.
Pulm. Pharmacol.
3:
47-51,
1989.
31.
Russell, J. A.
Responses of isolated canine airways to electric stimulation and acetylcholine.
J. Appl. Physiol.
45:
690-698,
1978
32.
Stephens, N. L.,
A. Halayko,
and
H. Jiang.
Normalization of contractile parameters in canine airway smooth muscle: morphological and biochemical.
Can. J. Physiol. Pharmacol.
70:
635-644,
1992[Medline].
33.
Stephens, N. L.,
and
H. Jiang.
Basic physiology of airway smooth muscle.
In: Asthma and Rhinitis, edited by W. W. Busse,
and S. T. Holgate. Boston, MA: Blackwell Scientific, 1995, p. 1087-1115.
34.
Stephens, N. L.,
H. Jiang,
J. Xu,
and
W. Kepron.
Airway smooth muscle mechanics and biochemistry in experimental asthma.
Am. Rev. Respir. Dis.
143:
1182-1188,
1991[Medline].
35.
Taylor, S. M.,
P. D. Paré,
and
R. R. Schellenberg.
Cholinergic and nonadrenergic mechanisms in human and guinea pig airways.
J. Appl. Physiol.
56:
958-965,
1984
36.
Uddman, R.,
L. O. Cardell,
A. Luts,
and
F. Sundler.
Inhibitory nonadrenergic, noncholinergic innervation of airways smooth muscle: role of vasoactive intestinal peptide and structurally related molecules.
In: Airways Smooth Muscle: Structure, Innervation and Neurotransmission, edited by D. Raeburn,
and M. A. Giembycz. Basel: Birkhäuser, 1994, p. 143-156.
This article has been cited by other articles:
![]() |
C. Duracher, F.-X. Blanc, P.-Y. Gueugniaud, J. S. David, B. Riou, Y. Lecarpentier, and C. Coirault The Effects of Isoflurane on Airway Smooth Muscle Crossbridge Kinetics in Fisher and Lewis Rats Anesth. Analg., July 1, 2005; 101(1): 136 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-X. Blanc, O. Langeron, C. Coirault, S. Salmeron, F. Lambert, B. Riou, and Y. Lecarpentier Mechanical Properties of Tracheal Smooth Muscle Are Impaired in the Rabbit With Experimental Cardiac Pressure Overload Chest, January 1, 2004; 125(1): 236 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
F-X. Blanc, C. Coirault, S. Salmeron, D. Chemla, and Y. Lecarpentier Mechanics and crossbridge kinetics of tracheal smooth muscle in two inbred rat strains Eur. Respir. J., August 1, 2003; 22(2): 227 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lecarpentier, F.-X. Blanc, S. Salmeron, J.-C. Pourny, D. Chemla, and C. Coirault Myosin cross-bridge kinetics in airway smooth muscle: a comparative study of humans, rats, and rabbits Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L83 - L90. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |